LeMaitre Vascular Price to Book Ratio 2010-2023 | LMAT
Historical price to book ratio values for LeMaitre Vascular (LMAT) over the last 10 years. The current price to book ratio for LeMaitre Vascular as of March 28, 2024 is 5.02.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
LeMaitre Vascular Price/Book Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | Book Value per Share | Price to Book Ratio |
2024-03-28 | 66.36 | 4.97 | |
2023-12-31 | 56.62 | $13.34 | 4.24 |
2023-09-30 | 54.20 | $12.96 | 4.18 |
2023-06-30 | 66.77 | $12.75 | 5.24 |
2023-03-31 | 50.97 | $12.38 | 4.12 |
2022-12-31 | 45.44 | $12.14 | 3.74 |
2022-09-30 | 49.91 | $11.87 | 4.20 |
2022-06-30 | 44.75 | $11.75 | 3.81 |
2022-03-31 | 45.52 | $11.74 | 3.88 |
2021-12-31 | 49.07 | $11.59 | 4.23 |
2021-09-30 | 51.75 | $11.40 | 4.54 |
2021-06-30 | 59.36 | $8.99 | 6.60 |
2021-03-31 | 47.35 | $8.62 | 5.49 |
2020-12-31 | 39.22 | $8.41 | 4.66 |
2020-09-30 | 31.42 | $7.38 | 4.26 |
2020-06-30 | 25.42 | $7.56 | 3.36 |
2020-03-31 | 23.91 | $7.38 | 3.24 |
2019-12-31 | 34.38 | $7.35 | 4.68 |
2019-09-30 | 32.60 | $7.12 | 4.58 |
2019-06-30 | 26.62 | $6.96 | 3.82 |
2019-03-31 | 29.40 | $6.77 | 4.34 |
2018-12-31 | 22.36 | $6.64 | 3.37 |
2018-09-30 | 36.54 | $6.40 | 5.71 |
2018-06-30 | 31.52 | $6.24 | 5.05 |
2018-03-31 | 34.04 | $5.88 | 5.79 |
2017-12-31 | 29.86 | $5.70 | 5.24 |
2017-09-30 | 35.04 | $5.51 | 6.36 |
2017-06-30 | 29.18 | $5.20 | 5.61 |
2017-03-31 | 22.98 | $4.90 | 4.69 |
2016-12-31 | 23.59 | $4.71 | 5.01 |
2016-09-30 | 18.44 | $4.67 | 3.95 |
2016-06-30 | 13.23 | $4.49 | 2.95 |
2016-03-31 | 14.34 | $4.40 | 3.26 |
2015-12-31 | 15.89 | $4.25 | 3.74 |
2015-09-30 | 11.19 | $4.11 | 2.73 |
2015-06-30 | 11.04 | $3.99 | 2.77 |
2015-03-31 | 7.64 | $3.88 | 1.97 |
2014-12-31 | 6.94 | $3.93 | 1.77 |
2014-09-30 | 6.21 | $3.86 | 1.61 |
2014-06-30 | 7.43 | $3.92 | 1.90 |
2014-03-31 | 7.22 | $3.60 | 2.00 |
2013-12-31 | 7.14 | $3.63 | 1.97 |
2013-09-30 | 5.95 | $3.59 | 1.66 |
2013-06-30 | 5.78 | $3.55 | 1.63 |
2013-03-31 | 5.45 | $3.50 | 1.56 |
2012-12-31 | 5.02 | $3.48 | 1.45 |
2012-09-30 | 5.60 | $3.44 | 1.63 |
2012-06-30 | 5.21 | $3.43 | 1.52 |
2012-03-31 | 5.09 | $3.42 | 1.49 |
2011-12-31 | 5.09 | $3.40 | 1.50 |
2011-09-30 | 5.33 | $3.41 | 1.56 |
2011-06-30 | 6.04 | $3.41 | 1.77 |
2011-03-31 | 5.80 | $3.39 | 1.71 |
2010-12-31 | 5.75 | $3.38 | 1.70 |
2010-09-30 | 5.99 | $3.28 | 1.83 |
2010-06-30 | 4.76 | $3.16 | 1.51 |
2010-03-31 | 3.82 | $3.11 | 1.23 |
2009-12-31 | 4.25 | $3.07 | 1.38 |
2009-09-30 | 3.48 | $3.02 | 1.15 |
2009-06-30 | 2.69 | $2.91 | 0.92 |
2009-03-31 | 2.15 | $2.81 | 0.76 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $1.499B | $0.193B |
LeMaitre Vascular, Inc. is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects the people worldwide. LeMaitre develops, manufactures, and markets disposable and implantable vascular devices to address the needs of vascular surgeons and interventionalists. LeMaitre's diversified product portfolio consists of twelve well-known brand name products used in arteries and veins outside of the heart and are supported by a growing, specialized and highly trained organization of vascular sales professionals. LeMaitre Vascular offers a wide range of innovative products to vascular surgeons and interventionalists for improving procedure efficacy and minimizing patient recovery time. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $196.909B | 25.56 |
Stryker (SYK) | United States | $136.478B | 33.84 |
Medtronic (MDT) | Ireland | $115.414B | 16.34 |
EssilorLuxottica (ESLOY) | France | $103.810B | 0.00 |
Boston Scientific (BSX) | United States | $100.864B | 33.47 |
Lonza Group Ag (LZAGY) | Switzerland | $44.257B | 0.00 |
Haleon (HLN) | United Kingdom | $39.385B | 30.46 |
ResMed (RMD) | United States | $28.878B | 28.87 |
Terumo (TRUMY) | Japan | $27.930B | 39.32 |
Zimmer Biomet Holdings (ZBH) | United States | $27.196B | 17.54 |
Baxter (BAX) | United States | $21.679B | 15.81 |
Koninklijke Philips (PHG) | Netherlands | $18.879B | 15.06 |
Insulet (PODD) | United States | $11.830B | 62.20 |
Smith & Nephew SNATS (SNN) | United Kingdom | $11.515B | 0.00 |
Demant (WILYY) | Denmark | $11.278B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $9.969B | 29.70 |
BellRing Brands (BRBR) | United States | $7.702B | 41.41 |
Haemonetics (HAE) | United States | $4.271B | 21.84 |
Perrigo (PRGO) | Ireland | $4.263B | 12.19 |
GN Store Nord (GNNDY) | Denmark | $4.150B | 26.87 |
Lantheus Holdings (LNTH) | United States | $4.145B | 10.70 |
Envista Holdings (NVST) | United States | $3.697B | 14.09 |
Prestige Consumer Healthcare (PBH) | United States | $3.606B | 17.05 |
Neogen (NEOG) | United States | $3.347B | 32.21 |
QuidelOrtho (QDEL) | United States | $3.226B | 11.71 |
Green Thumb Industries (GTBIF) | United States | $3.155B | 100.00 |
ICU Medical (ICUI) | United States | $2.484B | 18.71 |
TG Therapeutics (TGTX) | United States | $2.404B | 778.50 |
Maravai LifeSciences Holdings (MRVI) | United States | $2.157B | 0.00 |
Verano Holdings (VRNOF) | United States | $2.151B | 0.00 |
Owens & Minor (OMI) | United States | $2.141B | 20.55 |
InMode (INMD) | Israel | $1.780B | 9.22 |
National Vision Holdings (EYE) | United States | $1.720B | 53.56 |
Agios Pharmaceuticals (AGIO) | United States | $1.636B | 0.00 |
AdaptHealth (AHCO) | United States | $1.510B | 11.36 |
AtriCure (ATRC) | United States | $1.458B | 0.00 |
Warby Parker (WRBY) | United States | $1.303B | 0.00 |
MacroGenics (MGNX) | United States | $0.934B | 0.00 |
Quanterix (QTRX) | United States | $0.873B | 0.00 |
Canopy Growth (CGC) | Canada | $0.870B | 0.00 |
BioLife Solutions (BLFS) | United States | $0.836B | 0.00 |
Evolus (EOLS) | United States | $0.811B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.771B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.716B | 15.47 |
TerrAscend (TSNDF) | Canada | $0.571B | 0.00 |
Valneva SE (VALN) | France | $0.553B | 0.00 |
Jin Medical (ZJYL) | China | $0.543B | 0.00 |
Phibro Animal Health (PAHC) | United States | $0.529B | 11.46 |
PetIQ (PETQ) | United States | $0.513B | 19.17 |
OraSure Technologies (OSUR) | United States | $0.470B | 7.77 |
ZimVie (ZIMV) | United States | $0.442B | 27.18 |
Biote (BTMD) | United States | $0.438B | 4.16 |
Surmodics (SRDX) | United States | $0.410B | 44.31 |
Zynex (ZYXI) | United States | $0.405B | 46.59 |
Viemed Healthcare (VMD) | United States | $0.364B | 36.08 |
Cerus (CERS) | United States | $0.325B | 0.00 |
Sanara MedTech (SMTI) | United States | $0.322B | 0.00 |
Aurora Cannabis (ACB) | Canada | $0.259B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.252B | 15.36 |
TriSalus Life Sciences (TLSI) | United States | $0.248B | 0.00 |
Organigram Holdings (OGI) | Canada | $0.216B | 0.00 |
Omeros (OMER) | United States | $0.215B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.213B | 0.00 |
Ayr Wellness (AYRWF) | United States | $0.189B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.183B | 0.00 |
High Tide (HITI) | Canada | $0.163B | 0.00 |
Jushi Holdings (JUSHF) | United States | $0.146B | 0.00 |
Fonar (FONR) | United States | $0.138B | 11.84 |
InterCure (INCR) | Israel | $0.115B | 19.46 |
Societal CDMO (SCTL) | United States | $0.115B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.114B | 0.00 |
FitLife Brands (FTLF) | United States | $0.106B | 20.70 |
MariMed (MRMD) | United States | $0.102B | 0.00 |
Safety Shot (SHOT) | United States | $0.094B | 0.00 |
Chimerix (CMRX) | United States | $0.090B | 0.00 |
Veru (VERU) | United States | $0.089B | 0.00 |
Brainsway (BWAY) | Israel | $0.087B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.084B | 0.00 |
Eagleford Energy (GRUSF) | United States | $0.080B | 43.99 |
Zevia PBC (ZVIA) | United States | $0.075B | 0.00 |
Eagle Pharmaceuticals (EGRX) | United States | $0.065B | 4.25 |
Cytosorbents (CTSO) | United States | $0.050B | 0.00 |
Apyx Medical (APYX) | United States | $0.049B | 0.00 |
Rockwell Medical (RMTI) | United States | $0.048B | 0.00 |
Bright Green (BGXX) | United States | $0.047B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.045B | 0.00 |
Modular Medical (MODD) | United States | $0.043B | 0.00 |
ImmuCell (ICCC) | United States | $0.041B | 0.00 |
United-Guardian (UG) | United States | $0.036B | 13.85 |
FSD PHARMA (HUGE) | Canada | $0.028B | 0.00 |
Agape ATP (ATPC) | $0.027B | 0.00 | |
Exagen (XGN) | United States | $0.027B | 0.00 |
Nephros (NEPH) | United States | $0.024B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.020B | 0.00 |
Flora Growth (FLGC) | United States | $0.018B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.015B | 0.00 |
GUARDION HEALTH (GHSI) | United States | $0.011B | 0.00 |
ProSomnus (OSA) | United States | $0.010B | 0.00 |
NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
GlucoTrack (GCTK) | United States | $0.007B | 0.00 |
Leafly Holdings (LFLY) | United States | $0.007B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
Sharps Technology (STSS) | United States | $0.005B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.004B | 0.00 |
Senestech (SNES) | United States | $0.004B | 0.00 |
Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
Smart For Life (SMFL) | United States | $0.001B | 0.00 |
Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
SNDL (SNDL) | Canada | $0.000B | 0.00 |